Related Experiment Video
Updated: Oct 21, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
Off-Label Use of Monoclonal Antibodies in Developing Countries
Fatemeh Alizadeh Bengar1, Parinaz Sadat Mahmoudi, Hossein Khalili
1Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Conclusions:
Rituximab was widely used in clinical practice; however, its implementation protocols and safety-monitoring practices varied considerably. In light of these findings, it is important to distinguish between off-label use and inappropriate use, and to ensure that treatment decisions are evaluated against current evidence, clinical guidelines, and indication-specific criteria.
More Related Videos
Related Concept Videos
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

